Representative Matters

Represented Southfield Capital in connection with a dividend recapitalization of its portfolio company, BioPharm Communications and the senior and subordinated financings related thereto. BioPharm specializes in the development and multichannel deployment of proprietary marketing programs for the pharmaceutical and biotechnology industries.

In the Press